{"transactions":[{"id":2388856,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":130283,"kind":"person","name":"Dick Evan G.","position":1,"cik":"0001862116","reported_name":"Dick Evan G.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Section 16 officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-17T16:56:48.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":29223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments with 1/13th vesting on the last day of the calendar month in which the grant occurs and 1/13th on the last day of each subsequent month until fully vested on February 28, 2023. Additionally, 29,225 previously granted but unvested restricted stock units were cancelled as of December 30, 2021."}],"balance_after":29223,"derivative":{"exercise_price":2.05,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001842952-22-000016","document":"wf-form4_164513498176142.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862116/000184295222000016/wf-form4_164513498176142.xml","form_type":"4"}},{"id":2466639,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":130283,"kind":"person","name":"Dick Evan G.","position":1,"cik":"0001862116","reported_name":"Dick Evan G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of R&D"}}],"security":"Series Seed Preferred Stock","published_at":"2021-12-17T16:12:39.000Z","date":"2021-10-22","kind":"exercise","acquired":false,"shares":26587,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":26587},"source":{"system":"sec-edgar","filing":"0001842952-21-000025","document":"wf-form4a_163977554088927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862116/000184295221000025/wf-form4a_163977554088927.xml","form_type":"4/A","original_submission_date":"2021-10-22"}},{"id":2466638,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":130283,"kind":"person","name":"Dick Evan G.","position":1,"cik":"0001862116","reported_name":"Dick Evan G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of R&D"}}],"security":"Common Stock","published_at":"2021-12-17T16:12:39.000Z","date":"2021-10-22","kind":"exercise","acquired":true,"shares":26587,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 33,397 restricted stock units which fully vest on January 31, 2023."}],"balance_after":82960,"source":{"system":"sec-edgar","filing":"0001842952-21-000025","document":"wf-form4a_163977554088927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862116/000184295221000025/wf-form4a_163977554088927.xml","form_type":"4/A","original_submission_date":"2021-10-22"}},{"id":2535672,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":130283,"kind":"person","name":"Dick Evan G.","position":1,"cik":"0001862116","reported_name":"Dick Evan G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of R&D"}}],"security":"Series Seed Preferred Stock","published_at":"2021-10-25T17:29:56.000Z","date":"2021-10-22","kind":"exercise","acquired":false,"shares":26587,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":26587},"source":{"system":"sec-edgar","filing":"0001179110-21-009608","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862116/000117911021009608/edgar.xml","form_type":"4"}},{"id":2535671,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":130283,"kind":"person","name":"Dick Evan G.","position":1,"cik":"0001862116","reported_name":"Dick Evan G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of R&D"}}],"security":"Common Stock","published_at":"2021-10-25T17:29:56.000Z","date":"2021-10-22","kind":"exercise","acquired":true,"shares":26587,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 39,659 restricted stock units which fully vest on February 24, 2023."}],"balance_after":87139,"source":{"system":"sec-edgar","filing":"0001179110-21-009608","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862116/000117911021009608/edgar.xml","form_type":"4"}}]}